Brenntag SE shares tumble after Jefferies slashes rating to 'Underperform'
Brenntag SE, a global chemical distributor, is facing renewed pressure after a series of analyst downgrades. The company's shares dipped following a downgrade to 'Underperform' by Jefferies, which set a price target of €42—suggesting a potential 15% decline from current levels. Meanwhile, broader challenges in the chemical sector continue to weigh on performance.
The stock closed at €49.20 on March 13, 2026, after Jefferies cut its rating. Earlier in the week, shares had risen by 3.62%, trading between €47 and €50, with a weekly gain of 9.24%. By March 12, quotes fluctuated between €47.15 and €48.95, reflecting ongoing volatility.
The downgrade comes as Brenntag struggles with weak global demand and rising input costs. Its latest quarterly results highlighted persistent margin weakness, despite efforts to expand market share through acquisitions. Organic growth, however, remains difficult to achieve. Other analysts have also adjusted their outlook. Both Deutsche Bank and Warburg Research lowered their ratings to 'Hold', citing similar concerns. While Brenntag's business model benefits from price fluctuations in chemicals, the broader sector faces sluggish demand and tightening margins. Analysts expect only modest volume growth in 2026, primarily driven by specialty chemicals.
Brenntag SE's stock has shown slight gains but remains under pressure from market headwinds. The company's ability to navigate weak demand and cost pressures will be key in the coming months. For now, investor sentiment appears cautious amid the latest downgrades.
